🕒 Saturday 2 May 2026 Sat, 2 May 2026

Small caps drove the biggest moves, with Alvo Minerals surging, Klevo extending a payments-fuelled rally, and FBR jumping on fresh contract news. At the larger end, takeover bids, mine funding deals and a strong Liontown update kept resources and corporate activity at the centre of trading.

Payments and fintech names drove the biggest swings this week, while the major banks leaned on profit growth, asset sales and capital management. Investors also had to weigh cyber risk, legal penalties and weaker portfolio values as global tensions stayed in the background.

Big moves came from deal-driven small caps, critical minerals stories and a fresh burst of funding news across gold, copper and rare earths. The strongest gains came where cash, contracts or takeover terms gave investors something concrete to price in straight away.

Biotech price swings were led by Dimerix’s slide, while TrivarX and LTR Pharma surged on clinical and commercial progress. Capital raisings, FDA milestones and first sales kept healthcare investors busy, but several early jumps faded as traders locked in gains.

Robotics, AI chips and defence software drove the week’s biggest technology moves, but not every early jump held. Investors chased clear revenue growth and contract wins, while cash pressure and equity raisings kept a lid on parts of the sector.